Loading provider…
Loading provider…
Allergy & Immunology Physician in San Diego, CA
NPI: 1285654889Primary Employer
UCSD Medical Group
health.ucsd.edu
HQ Phone
Get MD Marc's Phone Numberphone_androidMobile
Get MD Marc's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2001 - 2027

American Board of Allergy and Immunology
Allergy & Immunology
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Allergy and Immunology
2001 - 2003
Washington University/B-JH/SLCH Consortium
Residency • Internal Medicine
1998 - 2001
Pritzker School of Medicine
pritzker.uchicago.edu
Medical School
Until 1998
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 71 | 107 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 38 | 52 |
| 3 | 36415Insertion of needle into vein for collection of blood sample | 35 | 39 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 22 | 25 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 17 | 17 |
Recombinant human C1 esterase inhibitor in the management of hereditary angioedema.
Authors: @ValidYN, LastName, ForeName, Initials, AffiliationInfo
Journal: Clin Drug Investig
Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.
Authors: Donald Levy, Jonathan Bernstein, Richard Gower, Timothy Craig, William Lumry, Bruce Zuraw, Aleena Banerji, Huamin Li
Publication Date: 2021-07
Lead Sponsor: Shire
Intervention / Treatment: DRUG: Placebo, DRUG: DX-2930
Lead Sponsor: Shire
Collaborators: PPD Development, LP
Intervention / Treatment: DRUG: Placebo, DRUG: Icatibant
Lead Sponsor: University of California, Los Angeles
Collaborators: Merck Sharp & Dohme LLC